Mimedx (MDXG) Interest & Investment Income (2023 - 2026)
Mimedx recorded quarterly Interest & Investment Income of $886000.0 in Q1 2026, down 1.99% quarter-over-quarter from $904000.0 in Q4 2025, and up 75.1% year-over-year from $506000.0 in Q1 2025.
Mimedx's Interest & Investment Income history runs 4 years deep, the most recent figure standing at $886000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 75.1% year-over-year to $886000.0; the TTM figure through Mar 2026 stood at $3.3 million (up 178.4% YoY), while the FY2025 annual figure was $2.9 million, up 391.55% from the prior year.
- Interest & Investment Income came in at $886000.0 for Q1 2026 at Mimedx, down from $904000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $904000.0 in Q4 2025 to a low of -$1.7 million in Q1 2024.
- A 4-year average of -$174166.7 and a median of $340500.0 in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 24500.0% in 2025 and surged 75.1% in 2026, its largest moves.
- Mimedx's Interest & Investment Income stood at -$1.6 million in 2023, then surged by 125.3% to $403000.0 in 2024, then soared by 124.32% to $904000.0 in 2025, then dropped by 1.99% to $886000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $886000.0, $904000.0, and $785000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 886,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 886,000.00 |
| Dec 31, 2025 | 904,000.00 |
| Sep 30, 2025 | 785,000.00 |
| Jun 30, 2025 | 738,000.00 |
| Mar 31, 2025 | 506,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 278,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -1.69 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.68 Mn |
| Jun 30, 2023 | -1.63 Mn |